Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Aleph-7

From Wikipedia, the free encyclopedia
Pharmaceutical compound
Aleph-7
Clinical data
Other namesALEPH-7; DOT-7; 4-Propylthio-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-4-propylthioamphetamine; 4-PrS-DMA
Routes of
administration
Oral[1]
Drug classSerotonin receptor modulator;Serotonin 5-HT2A receptor agonist;Serotonergic psychedelic;Hallucinogen;Monoamine oxidase inhibitor;Reversible inhibitor of MAO-A
ATC code
  • None
Pharmacokinetic data
Duration of action15–30 hours[1]
Identifiers
  • 1-(2,5-dimethoxy-4-propylsulfanylphenyl)propan-2-amine
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC14H23NO2S
Molar mass269.40 g·mol−1
3D model (JSmol)
  • CCCSC1=C(C=C(C(=C1)OC)CC(C)N)OC
  • InChI=1S/C14H23NO2S/c1-5-6-18-14-9-12(16-3)11(7-10(2)15)8-13(14)17-4/h8-10H,5-7,15H2,1-4H3
  • Key:XHWDHFUBCVWXDZ-UHFFFAOYSA-N

Aleph-7, orALEPH-7, also known as4-propylthio-2,5-dimethoxyamphetamine, is apsychedelic drug of thephenethylamine,amphetamine, andDOx families.[1] It is one of theAleph series of compounds.[1]

In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists Aleph-7's dose as 4 to 7 mgorally and itsduration as 15 to 30 hours.[1] The effects of Aleph-7 have been reported to include strangeness, slightvisual changes, intense but difficult to describealtered states of consciousness, everything feeling "preprogrammed",emotional changes, negative reactions, unwillingness to take the drug again,relaxation, andparesthesia, among others.[1] It was said to produce a "Beth state", defined as a state of uncaring,anhedonia, andemotionlesssness.[1] Many other drugs are also said to have a touch of such a state, but Aleph-7 to have more of it than most.[1]

It is apotentagonist of theserotonin5-HT2A receptor, with anEC50Tooltip half-maximal effective concentration of 2.2 to 7.6 nM and anEmaxTooltip maximal efficacy of 116 to 189%.[2] The drug is also a weakmonoamine oxidase inhibitor (MAOI), specifically areversible inhibitor of MAO-A (RIMA), with anIC50Tooltip half-maximal inhibitory concentration of 2.4 μM.[3][4]

Thechemical synthesis of Aleph-7 has been described.[1]

Aleph-7 was first described in thescientific literature by Shulgin in 1981.[5][6] Subsequently, it was described in greater detail by ShulginPiHKAL in 1991.[1] The drug was encountered as a noveldesigner drug inEurope in 2005.[7] It is acontrolled substance inCanada under phenethylamine blanket-ban language.[8]

See also

[edit]

References

[edit]
  1. ^abcdefghijShulgin, Alexander;Shulgin, Ann (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.https://erowid.org/library/books_online/pihkal/pihkal007.shtml
  2. ^Pottie E, Poulie CB, Simon IA, Harpsøe K, D'Andrea L, Komarov IV, Gloriam DE, Jensen AA, Kristensen JL, Stove CP (August 2023). "Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists".ACS Chem Neurosci.14 (15):2727–2742.doi:10.1021/acschemneuro.3c00267.hdl:1854/LU-01HKSP4M4EAJW6K41YXJ05T517.PMID 37474114.
  3. ^Reyes-Parada M, Iturriaga-Vasquez P, Cassels BK (2019)."Amphetamine Derivatives as Monoamine Oxidase Inhibitors".Front Pharmacol.10 1590.doi:10.3389/fphar.2019.01590.PMC 6989591.PMID 32038257.
  4. ^Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE (April 2005)."Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling".J Med Chem.48 (7):2407–2419.doi:10.1021/jm0493109.PMID 15801832.
  5. ^Shulgin AT (1980)."Hallucinogens". In Burger A, Wolf ME (eds.).Burger's Medicinal Chemistry. Vol. 3 (4 ed.). New York: Wiley. pp. 1109–1137.ISBN 978-0-471-01572-7.OCLC 219960627.
  6. ^Shulgin AT (1982)."Chemistry of Psychotomimetics". In Hoffmeister F, Stille G (eds.).Psychotropic Agents, Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs. Handbook of Experimental Pharmacology. Vol. 55. Berlin: Springer Berlin Heidelberg. pp. 3–29.doi:10.1007/978-3-642-67770-0_1.ISBN 978-3-642-67772-4.OCLC 8130916.
  7. ^King LA (2014). "New phenethylamines in Europe".Drug Test Anal.6 (7–8):808–818.doi:10.1002/dta.1570.PMID 24574327.
  8. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Non-specific
AAADTooltip Aromatic L-amino acid decarboxylase
MAOTooltip Monoamine oxidase
Phenethylamines
(dopamine,epinephrine,
norepinephrine)
PAHTooltip Phenylalanine hydroxylase
THTooltip Tyrosine hydroxylase
DBHTooltip Dopamine beta-hydroxylase
PNMTTooltip Phenylethanolamine N-methyltransferase
COMTTooltip Catechol-O-methyl transferase
Tryptamines
(serotonin,melatonin)
TPHTooltip Tryptophan hydroxylase
AANATTooltip Serotonin N-acetyl transferase
ASMTTooltip Acetylserotonin O-methyltransferase
Histamine
HDCTooltip Histidine decarboxylase
HNMTTooltip Histamine N-methyltransferase
DAOTooltip Diamine oxidase
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Aleph-7&oldid=1337551862"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp